Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly A Pike

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Immunological Reviews|February 14, 2004
The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell developmentKelly A Pike, Ehtesham Baig, Michael J H Ratcliffe
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
The cytoplasmic domain of Ig alpha is necessary and sufficient to support efficient early B cell developmentKelly A Pike, Sandra Iacampo, Jennifer E Friedmann, et al.
The Journal of Biological Chemistry|February 17, 2009
BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activationYasuhiro Imamura, Akihisa Oda, Takashi Katahira, et al.
Science Signaling|May 8, 2014
Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophagesKelly A Pike, Andrew P Hutchins, Valerie Vinette, et al.
Oncoimmunology|July 7, 2017
Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signalingClaudia Penafuerte, Matthew Feldhammer, John R Mills, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Reducing hERG Inhibition in the Design of Potent and Bioavailable Indazole cGAS InhibitorsPatrick Cyr, Amandine Chefson, Daniel V Sietsema, et al.
Clinical and Translational Science|April 30, 2026
First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 InhibitorLisanne C A Smidt, Matthijs Moerland, Manon A A Jansen, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided HybridizationPatrick Cyr, Lee D Fader, Jason D Burch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptorsNien-Jung Chen, Iok In Christine Chio, Wen-Jye Lin, et al.
Communications Chemistry|March 23, 2025
Structural insight into the cGAS active site explains differences between therapeutically relevant speciesAlexander M Skeldon, Li Wang, Nicolas Sgarioto, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Immunological Reviews|February 14, 2004
The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell developmentKelly A Pike, Ehtesham Baig, Michael J H Ratcliffe
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
The cytoplasmic domain of Ig alpha is necessary and sufficient to support efficient early B cell developmentKelly A Pike, Sandra Iacampo, Jennifer E Friedmann, et al.
The Journal of Biological Chemistry|February 17, 2009
BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activationYasuhiro Imamura, Akihisa Oda, Takashi Katahira, et al.
Science Signaling|May 8, 2014
Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophagesKelly A Pike, Andrew P Hutchins, Valerie Vinette, et al.
Oncoimmunology|July 7, 2017
Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signalingClaudia Penafuerte, Matthew Feldhammer, John R Mills, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Reducing hERG Inhibition in the Design of Potent and Bioavailable Indazole cGAS InhibitorsPatrick Cyr, Amandine Chefson, Daniel V Sietsema, et al.
Clinical and Translational Science|April 30, 2026
First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 InhibitorLisanne C A Smidt, Matthijs Moerland, Manon A A Jansen, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided HybridizationPatrick Cyr, Lee D Fader, Jason D Burch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptorsNien-Jung Chen, Iok In Christine Chio, Wen-Jye Lin, et al.
Communications Chemistry|March 23, 2025
Structural insight into the cGAS active site explains differences between therapeutically relevant speciesAlexander M Skeldon, Li Wang, Nicolas Sgarioto, et al.
Pageof 2